Effects of Abaloparatide, a Human Parathyroid Hormone-Related Peptide Analog, on Bone Mineral Density in Postmenopausal Women with Osteoporosis | Zendy

Benjamin Z. Leder | Zendy; Louis O’Dea | Zendy; José Zanchetta | Zendy; Prasana Kumar | Zendy; Kathleen Banks | Zendy; Kathleen E. McKay | Zendy; C. Richard Lyttle | Zendy; Gary Hattersley | Zendy

Open Access

Effects of Abaloparatide, a Human Parathyroid Hormone-Related Peptide Analog, on Bone Mineral Density in Postmenopausal Women with Osteoporosis

Author(s) -

Benjamin Z. Leder,

Louis O’Dea,

José Zanchetta,

Prasana Kumar,

Kathleen Banks,

Kathleen E. McKay,

C. Richard Lyttle,

Gary Hattersley

Publication year - 2014

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2014-3718

Subject(s) - teriparatide , osteoporosis , bone mineral , femoral neck , medicine , placebo , endocrinology , parathyroid hormone , bone remodeling , calcium , pathology , alternative medicine

Abaloparatide is a novel synthetic peptide analog of parathyroid hormone-related protein (PTHrP) that is currently being developed as a potential anabolic agent in the treatment of postmenopausal osteoporosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research